Skip to main content
. 2020 Aug 29;6(8):e04811. doi: 10.1016/j.heliyon.2020.e04811

Table 3.

MLR models for risk stratification. The table shows the best models for each pathway and corresponding gene set used. Patients with predicted OS less than or equal to the median cutoff are at higher risk than patients with predicted OS more than cutoff.

S. no. Pathway Gene set Regressor HR p-val C
1 NRF2 Combined Ridge 2.17 3 × 10−6 0.60
2 P53 Combined RF 2.04 1 × 10−5 0.59
3 Apoptosis GPM RF 2.24 1.2x10−6 0.59
4 WNT Combined RF 2.22 2 × 10−6 0.59
5 CELL-CYCLE Combined RF 1.76 5.7 × 10−3 0.59
6 PI3K-AKT Combined RF 1.90 8 × 10−5 0.60
7 TGF-β Combined KNN 1.73 9 × 10−4 0.58
8 NOTCH Combined Lasso 2.34 3 × 10−7 0.62
9 MYC GPM Lasso 1.68 1.7 × 10−3 0.57
10 RAS Combined Lasso 1.79 3.8 × 10−4 0.58
11 HIPPO Combined KNN 1.11 0.51 0.52
12 Apoptosis + NOTCH GPM + Combined RF 2.54 2.3x10−8 0.61

∗Boldface indicates the best results. Hyperparameters for above models are provided in Supplementary S1 TableC.